Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2022, Vol. 27 ›› Issue (11): 1247-1254.doi: 10.12092/j.issn.1009-2501.2022.11.006

Previous Articles     Next Articles

Cordyceps sinensis extracts attenuates HBx-induced mesangial cell proliferation and extracellular matrix synthesis by suppression of the PI3K/Akt pathways

LEI Jing, HE Ping, CAI Wenlin, ZHANG Yongzhe, ZHANG Beiru, LIU Dajun   

  1. Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning, China
  • Received:2022-04-01 Revised:2022-10-21 Online:2022-11-26 Published:2022-12-12

Abstract:

AIM: To investigate the effect of C.sinensis extracts on HBx (Hepatitis B virus X protein) induced cell proliferation and extracellular matrix (ECM) accumulation and the underlying mechanism in cultured human mesangial cells (HMCs). METHODS: Human mesangial cells were stable transfected with pCMV-HBx to establish an HBx over-expression model, and a control group was transfected with an empty vector. Cell proliferation was determined by MTT assay and DNA synthesis assay. Western blotting was used to measure the expression of PI3K/Akt signaling pathway-related proteins and extracellular matrix.RESULTS: HBx transfection induced cell proliferation, matrix accumulation. HBx-transfected mesangial cells had increased activity of the PI3K/Akt pathways, and treatment with C.sinensis suppressed this effect. CONCLUSION: C.sinensis attenuates the HBx-induced human mesangial cell proliferation and matrix production in human mesangial cells via inhibition of the PI3K/Akt pathways.

Key words: cordyceps sinensis, proliferation, matrix accumulation, PI3K/Akt, HBx, human mesangial cells

CLC Number: